普伐他汀联合罗格列酮上调冠心病患者单核细胞ABCA1表达
出处
《基础医学与临床》
CSCD
北大核心
2010年第10期1096-1097,共2页
Basic and Clinical Medicine
基金
湖北省教育厅科学技术研究计划中青年人才项目(B200792004)
参考文献3
-
1王秀萍,容春莉,于薇,李如意,彭应心,齐晓勇.阿托伐他汀抑制THP-1经PMA诱导后变成巨噬细胞ATP结合盒转运子A1mRNA和蛋白的表达[J].基础医学与临床,2007,27(3):310-313. 被引量：1
-
2李华波,全智华,杨薪,李颖庆.罗格列酮对冠心病患者外周血单核细胞三磷酸腺苷结合盒转运子A1表达的影响[J].中国动脉硬化杂志,2006,14(8):685-688. 被引量：6
-
3Yano M, Matsumura T, Senokuchi T, et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogenactivated protein kinase-dependent cyclooxygenase-2 expression in macrophages [J]. Circ Res, 2007, 100:1442- 1451.
二级参考文献14
-
1Oram JF.HDL apolipoproteins and ABCA1 partners in the removal of excess cellular cholesterol[J].Arterrioscler Thromb Vasc Biol,2003,23 (5):720-727
-
2Chinett G,Lestavel S,Bocher V,Remaley AT,Neve B,Torra IP,et al.PPAR-α and PPAR-γ activators induce cholesterol from human macrophage foam cells through stimulation of the ABCA1 pathway[J].Nat Med,2001,7 (1):53-58
-
3Chinetti G,Lestavel S,Fruchart JC,Clavey V,Staels B Peroxisome proliferator-activated receptor α (PPARα) reduces cholesterol esterification in macrophages[J].Circulation Research,2003,92 (2):212-217
-
4Argmann CA,Sawyez CG,McNeil CJ,Hegele RA,Huff MW.Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins[J].Arterioscler Thromb Vasc Biol,2003,23 (3):457-482
-
5Brooks Wilson A,Marcil M,Clee SM,Zhang LH,Roomp K,van Dam M,et al.Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency[J].Nat Genet,1999,22 (4):336-345
-
6Bodzioch M,Orso E,Klucken J,Langmann T,Bottcher A,Diederich W,et al.The gene encoding ATP-binding cassette transporter l is mutated in Tangier disease[J].Nat Genet,1999,22 (4):347-351
-
7Smith JD,Le Goff WL,Settle M,Brubaker G,Waelde C,Horwitz A,et al.ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I[J].J Lipid Res,2004,45 (4):635-644
-
8Wang M,Wise SC,Leff T,Su TZ.Troglitazone,an antidiabetic agent,inhabits cholesterol biosynthesis through a mechanism independent of peroxisome proliferators-activated receptor-gamma[J].Diabetes,1999,48 (2):254-260
-
9Hodgkinson CP,Ye S.Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages[J].Biochem Biophys Res Commun,2003,308 (3):505-510
-
10Akiyama TE,Sakai S,Lambert G,Nicol CJ,Matsusue K,Pimprale S,et al.Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1,ABCG1,and apoE in macrophages and reduced cholesterol efflux[J].Mol Cell Biol,2002,22 (8):2 607-619
共引文献5
-
1韩君勇,李艳波,谭劼.高压力及曲格列酮对THP-1源泡沫细胞ATP结合盒转运子A1表达的影响[J].中国现代医学杂志,2009,19(6):868-871.
-
2彭扬,王玉霞,李慧,孟馨.罗格列酮抑制高糖诱导的内皮细胞黏附作用[J].中国动脉硬化杂志,2009,17(3):185-188. 被引量：2
-
3苟连平,秦俭,吕湛,凡瞿明,程田兵,冯静.罗格列酮对急性冠脉综合征患者外周血单核细胞ABCA1蛋白表达的干预[J].重庆医科大学学报,2009,34(6):718-721. 被引量：1
-
4卞景慧,李轶群.罗格列酮治疗2型糖尿病的临床应用分析[J].社区医学杂志,2009,7(18):15-16. 被引量：1
-
5贾军正,李万玲,郭文芬,王志禄,徐芳,蒙颖.罗格列酮对兔早期动脉粥样硬化白细胞介素-6、白细胞介素-8表达的影响[J].国际心血管病杂志,2012,39(6):372-376. 被引量：1
-
1李华波,全智华.ABCA1与PPARs在胆固醇流出中的作用及相关性[J].医学综述,2005,11(11):974-976. 被引量：5
-
2王胜煌,陈晓敏,张福兴,储慧民,王勇,潘伟民,叶红华,崔翰斌,崔长琮.候选基因ABCAl-G596A变异与冠心病发病的关系[J].心脑血管病防治,2008,8(1):18-20.
-
3王丽,袁托亚,王悦喜.冠心病病人ABCA1基因单核苷酸多态性检测的意义[J].内蒙古医学院学报,2008,30(5):393-396. 被引量：1
-
4王玉明,李亚,郑人源,潘克俭.ATP结合盒转运体A1基因R219K多态与冠心病的相关性研究[J].成都医学院学报,2006,1(2):102-105. 被引量：1
-
5田慧,韩越,吴秀萍,杨玉玲,王雪婷.ABCA1和PPARγ与糖尿病动脉粥样硬化关系的研究[J].现代生物医学进展,2013,13(3):452-455. 被引量：2
-
6郭茜,高清歌,刘静.ABCA1基因R219K多态性与2型糖尿病合并冠心病患者脂代谢特性的关系[J].中国糖尿病杂志,2010,18(11):827-830. 被引量：2
-
7张涛,李红兵,王东琦,崔翰斌,张爱峰.ATP结合盒转运体A1基因G596A变异对血脂的影响[J].岭南心血管病杂志,2006,12(5):316-319. 被引量：1
-
8张霞,任颖,刘伟,郑升,骆天红,罗敏.ATP结合盒转运体A1基因多态性与2型糖尿病及肥胖的相关性[J].上海交通大学学报（医学版）,2006,26(9):961-964.
-
9侯荣耀,朱晓岩,潘旭东,郭瑞友,马腾,徐翔.ATP结合盒转运体A1基因R219K多态性与中国人缺血性卒中风险：汇总分析[J].国际脑血管病杂志,2013,21(7):517-521. 被引量：2
-
10韩君勇,李艳波,田慧,许智博.巨噬细胞中ABCA1表达及曲格列酮干预的影响[J].哈尔滨医科大学学报,2008,42(6):591-593.
